Peer Review History
| Original SubmissionJune 17, 2020 |
|---|
|
PONE-D-20-18632 Pre-exposure to mechanical ventilation and endotoxemia additively increases Pseudomonas aeruginosa growth in lung tissue during experimental porcine pneumonia PLOS ONE Dear Dr. Sperber, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Experimental work expanding our knowledge on lung physiology and pathology through studies into large animal models are highly appreciated. It is accepted that such studies are limited in the numbers of animals that can be included as well as in e.g. immunological parameters that can be analysed. However, as you may see from the detailed comments below, we would greatly appreciate if you could add some additional analyses from the BAL samples collected. Because you did not only collect BAL at the end of the experiment but also at -24h and 0h, respectively, TNF-alpha and IL-6 measurements at the other time points should be included. Such analyses should also comprise cell differentials to get an idea of the changes in immune cell composition in the alveolar space as well as additionally cytokines relevant at earlier time points of the pathologic processes in the lung. Data regarding BAL total protein should also be included. Further, the comments regarding the biostatistical analyses have to be considered. A detailed point-by-point response to the reviewers' comments will be mandatory. Please submit your revised manuscript by Sep 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Heinz Fehrenbach Academic Editor PLOS ONE Additional Editor Comments: I have a few additional comments expanding on what reviewer #1 (see below) stated. - In the statistics part you state "Comparative group statistics in the experimental parts Inflammation (A30h+Etx vs. B30h) and Ventilation Time (B30hvs. C6h) were based on data from the last 6 h of the experiment (the bacterial phase). No multigroup comparisons including all three groups were used in the experiment." However, you used group B30h twice in your statitics, which means that you apparently treated the setting as two independent experiments. This is clearly not the case. Although being no biostatistician, I think you have to adjust the level of significanse to the fact that you used group B30h twice. - In the conclusion part of the abstract you state: "Mechanical ventilation and systemic inflammation before the onset of pneumonia additively increase the growth of P. aeruginosa in lung tissue." I do not think that you are able to demonstrate additivity of the effects with your setting and I also cannot find a discussion of this aspect in the manuscript. Because the abstract should contain only well supported statements, I suggest that you remove this sentence or at least consderably modify it to comply with your results. - Please translate all terms in the supplemnetal material to English language. Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for including your ethics statement: 'The Animal Research Ethics Board of Uppsala issued the permit for the experiment (Uppsala djurförsöksetiska nämnd, DNr C 250/11).' (a) Please amend your current ethics statement to include whether the Animal Research Ethics Board of Uppsala specifically approved your study. (b) Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to " ext-link-type="uri" xlink:type="simple">http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research." 3. At this time, we request that you please report additional details in your Methods section regarding animal care, as per our editorial guidelines: (a) Please state the source and number of mice used in the study (b) Please provide details of animal welfare (e.g., shelter, food, water, environmental enrichment) (c) Please provide the name and dosage of the specific anaesthetic agent used in your study (d) Please include the method of euthanasia Thank you for your attention to these requests. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Study by Sperber et al. The study reports on the Pseudomonas aeruginosa growth of lung tissues after pre-exposure to mechanical ventilation with or without endotoxin-induced systemic inflammation in large animal (pig) models. From interpretation point of view, there were three groups and two comparable parts in current study: Group #1-A30h+Etx: endotoxin(+) + mechanical ventilation(+) + bacterial inoculation(+) Group #2-B30h: endotoxin(-) + mechanical ventilation(+) + bacterial inoculation(+) Group #3-C6h: endotoxin(-) + mechanical ventilation(-) + bacterial inoculation(+) Comparable part #1-inflammation: A30h+Etx vs B30h Comparable part #2-ventilation time: B30h vs C6h The authors sampled lung tissues of three different regions (cranial, middle, and caudal) from both right and left lung of the same animal based on the heterogeneity of lung injury in large animals. Bacterial growth (colony forming unit) and lung edema (wet-to-dry ratio) from lung tissues are assessed as well as cytokines (TNF-α, IL 6 and 10) in bronchoalveolar lavage (BAL) and plasma to measure lung and systemic inflammation. The authors found significant bacterial growth of lung tissues in animals pre-exposed to mechanical ventilation and additionally to systemic inflammation for 24 hours. Lung edema was severe in A30h+Etx, and mild in B30h. The authors also found higher plasma TNF-α in C6h when compared to B30h. No differences of bacterial growth and cytokine levels in BAL between the groups were observed. This is an observational study on an important clinical topic performed in large animals. The methodology in this study is complete, and the statistical analysis appears appropriate. However, no mechanisms were investigated. Also, the causal relationship between each observation (bacterial growth, lung edema and systemic inflammation) seems not clear and needs to be improved. Major comments: 1) From my understanding that the cytokines TNF-α and IL6 are the early responded factors during inflammation, it is anticipated that these cytokines would decrease or return to the normal levels later, as the results presented in current study. Thus, it's not clear why the authors measured TNF-α and IL6 at the end of current studies (the time periods were approximately 30 hours). Also, the higher levels of TNF-α in C6h might be due to the time frame after bacterial infection, in which time period TNF-α increased. Could the authors clarify these? 2) In terms of cytokines TNF-α and IL6 mainly produced by macrophages, these results in current studies might reflect the functional role for circulatory macrophages. How about the other immune cells, such as neutrophils, as they also play important roles in bacterial infection and clearance? It would be better if the authors could provide some evidence (such as other cytokines) to indicate the functional activity for other immune cells. 3) Due to the infection of P. aeruginosa in lung, I am curious about the local lung injury after pneumonia. In terms of lung damage, the authors measured oxygen index (PaO2/FiO2), wet-to-dry ratio, and cytokines in BAL. There was difference only in wet-to-dry ratio in each comparison. Since the lung tissues and BAL were harvested in current study, could the authors provide more measurements for lung damage, such as protein concentration in BAL, histological lung injury staining, cytokines and surfactants in lung tissues? These results would not only help support local lung injury after bacterial infection, but also might provide some potential explanation for bacterial growth. 4) In discussion of experimental part: A30h+Etx vs B30h, the authors discussed the potential effect of TNF-α peak and lung edema existed in A30h+Etx on impairing the immune system’s ability, which subsequently reduced bacterial growth. The results did not show difference in cytokines of BAL and plasma in A30h+Etx vs B30h at the end of study. Could the authors explain this? It would be more strength if the authors could provide more other evidences for the compromise immunity. 5) Page 26/Line 427-428: "Therefore, the higher TNF-α response to the bacterial challenge in C6h is an indication of the preserved functionality of the alveolar macrophages, ...". I think there would be "the higher plasma TNF-α response...". Could the authors improve the statement? How to explain the results of no difference of TNF-α in BAL between B30h and C6h, based on the preserved functionality of the alveolar macrophages in C6h? 6) Page26/Ling 438-441: "The attenuated edema formation in group B30 suggests a relatively lower activation of neutrophils which, in turn, could explain the higher bacterial growth, supposedly associated with relatively lower bactericidal capacity." In the discussion, the reason for the attenuated edema in B30h was attributed to the relatively lower activation of neutrophils. Could the authors provide the evidence for the lower activity of neutrophils in lung? This would enhance the strength of this statement and support the finding of higher bacterial growth. Minor comments: 7) Page 9/Line 41 in Abstract: "A third group, C6h (n=8), ...". Please improve the description of the group C6h. 8) Page 9/Line 46-49: the results of abstract. Given there were two comparisons: A30h+Etx vs B30h and B30h vs C6h, it's not clear what comparison the P-values in results indicated. Could the authors describe these most important findings using numerical results (and statistical significance)? 9) Page 13/Line 140-142: "The alveolar recruitment maneuver (ARM) consisted of stepwise increments of PEEP until the peak pressure reached 35 cm H2O, followed by prolonged inspiration for 10 seconds (s)." Could the authors provide the details for the stepwise increments of PEEP (#-# cmH2O)? 10) Page 16/Line 216-220, the authors reported no difference of bacterial growth and wet-to-dry ratios between right and left sided lung. Could the authors improve the presentation of raw data from right and left side (supplementary Figure 1a and 2a) in each group, but not in all groups? 11) The P-value presented in Supplementary Figure 3 was a little bit confused based on only two comparable parts in this study. Could the authors clearly show the P values for each effect: inflammation, ventilation time and their interaction, in the figure legend of in the plot? 12) Page 21/Line 311: "The highest bacterial growth was in B30h (Figure 2)." Based on the comparison between B30h and C6h, perhaps it's better to present the data as: "The higher bacterial growth was in B30h...". 13) Page 26/Line 438-439: "The attenuated edema formation in group B30 suggests a relatively lower activation of neutrophils..." Please correct the group name "B30h". 14) Page 25/Line 411-412: "This result indicates a major edema development in B30h+Etx only after the bacterial challenge." Here I think the group should be A30h+Etx. Reviewer #2: The topic of this article is very interesting and relevant. I have just a few comments to make: 1) Although the hypothesis and research questions are well defined, were there any kind of sample size calculation 2) Please report data as mean and SD not as mean and sEM, especially since you have unequal group sizes. 3) I suggest tol elaborate a bit more the clinical / translational meaning of your findings. 4) Please comment why you did the inoculation in a blind way. Given the species it would have been easy to deliver everything in a very standardized way e.g. using fiberoptic bronchoscopy. 5) I suggest to explain also in this papers method section why you did not perform a sample size calculation. In my opinion crossreferencing is not sufficient in this case. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Pre-exposure to mechanical ventilation and endotoxemia increases Pseudomonas aeruginosa growth in lung tissue during experimental porcine pneumonia PONE-D-20-18632R1 Dear Dr. Sperber, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Heinz Fehrenbach Academic Editor PLOS ONE Additional Editor Comments (optional): All my specific comments were adequately addressed. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for addressing all my concerns to great detail. Authors also performed additional work. The manuscript has significantly improved. I have no additional questions. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-18632R1 Pre-exposure to mechanical ventilation and endotoxemia increases Pseudomonas aeruginosa growth in lung tissue during experimental porcine pneumonia Dear Dr. Sperber: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr. Heinz Fehrenbach Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .